Collectively, these studies demonstrate that synthetic anti-inflammatory compounds and retinoid derivatives effectively counteract BCL–2–mediated resistance in HTLV-1-associated ATLL by restoring apoptotic signaling. The gene discussed is BCL2; the disease is adult T-cell leukemia/lymphoma.